LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 44 filers reported holding LYRA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,882,067 | -4.9% | 12,757,562 | 0.0% | 1.66% | +9.6% |
| Q2 2023 | $52,433,579 | +185.2% | 12,757,562 | +39.5% | 1.52% | +179.6% |
| Q1 2023 | $18,384,927 | -36.0% | 9,146,730 | 0.0% | 0.54% | -32.6% |
| Q4 2022 | $28,720,732 | -37.3% | 9,146,730 | 0.0% | 0.81% | -39.4% |
| Q3 2022 | $45,825,000 | -11.3% | 9,146,730 | 0.0% | 1.33% | -17.9% |
| Q2 2022 | $51,679,000 | +298.9% | 9,146,730 | +183.8% | 1.62% | +522.7% |
| Q1 2022 | $12,955,000 | -53.9% | 3,222,560 | -50.0% | 0.26% | +19.8% |
| Q4 2021 | $28,100,000 | -4.4% | 6,445,120 | +100.0% | 0.22% | -49.2% |
| Q3 2021 | $29,403,000 | -43.2% | 3,222,560 | -50.0% | 0.43% | +27.1% |
| Q2 2021 | $51,754,000 | +38.6% | 6,445,120 | +100.0% | 0.34% | -28.8% |
| Q1 2021 | $37,349,000 | +1.7% | 3,222,560 | -0.0% | 0.47% | +19.8% |
| Q4 2020 | $36,737,000 | +2.0% | 3,222,561 | 0.0% | 0.39% | -25.1% |
| Q3 2020 | $36,028,000 | -1.4% | 3,222,561 | 0.0% | 0.53% | -11.1% |
| Q2 2020 | $36,543,000 | – | 3,222,561 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,484,000 | 9.72% |
| Perceptive Advisors | 3,222,561 | $36,543,000 | 0.59% |
| Soleus Capital Management, L.P. | 60,670 | $687,000 | 0.39% |
| PURA VIDA INVESTMENTS, LLC | 198,011 | $2,245,000 | 0.22% |
| RA Capital Management | 815,849 | $9,252,000 | 0.18% |
| ExodusPoint Capital Management, LP | 83,502 | $947,000 | 0.02% |
| ArrowMark Colorado Holdings LLC | 200,180 | $2,270,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 30,000 | $340,000 | 0.01% |
| Pentwater Capital Management LP | 23,800 | $270,000 | 0.01% |
| Blackstone Inc. | 25,000 | $284,000 | 0.00% |